Elanco
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1954-01-01
- Employees
- -
- Market Cap
- $7.5B
- Website
- https://www.elanco.com/
Neurizon Therapeutics Repurposes Monepantel for MND Treatment in Healey ALS Platform Trial
Neurizon Therapeutics (formerly PharmAust) is repurposing monepantel, an existing animal drug, for the treatment of motor neuron disease (MND).